We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Demand for cardiovascular and blood-thinning drugs has soared as COVID-19 cases have peaked, according to data from Premier, a healthcare improvement company. Read More
Moderna has signed a 10-year agreement with Swiss manufacturer Lonza to manufacture its COVID-19 vaccine candidate and other future products. Read More
The FDA on Friday granted Gilead’s remdesivir an Emergency Use Authorization (EUA) as a COVID-19 treatment, based on positive results from two clinical trials. Read More
The device uses components that are not in the medical device supply chain, meaning it will not impact the manufacturing of existing ventilators, the agency said. Read More